Do patients with type 2 diabetes underestimate their risk of cardiovascular disease?
The International Diabetes Federation, in partnership with the pharmaceutical company, Novo Nordisk, is conducting the first global online survey of patients living with type 2 diabetes, to evaluate their awareness and knowledge of cardiovascular risk.